News
- Author:
- Elizabeth Mechcatie
Publish date: November 6, 2013
News
- Author:
- Elizabeth Mechcatie
Publish date: November 6, 2013
Major finding: Eleven cases of hepatic failure were identified among almost 334 reports of serious adverse events associated with boceprevir treat...
News
- Author:
- Elizabeth Mechcatie
Publish date: November 5, 2013
Major finding: Treatment with sofosbuvir and ribavirin resulted in SVR12 rates of 76%, 88%, and 67%, for those infected with HIV and HCV genotypes...
News
- Author:
- Elizabeth Mechcatie
Publish date: November 5, 2013
Major finding: Treatment with sofosbuvir and ribavirin resulted in SVR12 rates of 76%, 88%, and 67%, for those infected with HIV and HCV genotypes...
News
- Author:
- Elizabeth Mechcatie
Publish date: November 5, 2013
Major finding: Cases of liver injury from all herbal and dietary supplements increased from 7% in 2004-2005 to 20% in 2010-2012.
News
- Author:
- Elizabeth Mechcatie
Publish date: November 5, 2013
Major finding: All treatment-experienced HCV patients reached SVR12 with a fixed-dose combination of sofosbuvir and ledipasvir when ribavirin was ...
News
- Author:
- Elizabeth Mechcatie
Publish date: November 1, 2013
News
- Author:
- Elizabeth Mechcatie
Publish date: November 1, 2013
Major finding: In a study of 500 patients with chronic hepatitis C patients who developed anemia while on triple therapy, the sustained virologic ...
News
- Author:
- Elizabeth Mechcatie
Publish date: November 1, 2013
News
- Author:
- Elizabeth Mechcatie
Publish date: November 1, 2013
Major finding: In a study of 500 patients with chronic hepatitis C patients who developed anemia while on triple therapy, the sustained virologic ...
News
- Author:
- Elizabeth Mechcatie
Publish date: October 31, 2013
News
- Author:
- Elizabeth Mechcatie
Publish date: October 28, 2013
News
- Author:
- Elizabeth Mechcatie
Publish date: October 25, 2013
News
- Author:
- Elizabeth Mechcatie
Publish date: October 25, 2013
News
- Author:
- Elizabeth Mechcatie
Publish date: October 21, 2013
